Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group

A. Schinstock, Carrie; B. Mannon, Roslyn; Budde, Klemens; S. Chong, Anita; Haas, Mark; J. Knechtle, Stuart; Lefaucheur, Carmen; A. Montgomery, Robert; Nickerson, Peter; G. Tullius, Stefan; Ahn, Curie; Askar, Medhat; Crespo, Marta; J. Chadban, Steven; Feng, Sandy; C. Jordan, Stanley; Man, Kwan; Mengel, Michael; E. Morris, Randall; O’Doherty, Inish; Handan Özdemir, B.; Serón, Daniel; R. Tambur, Anat; Tanabe, Kazunari; Taupin, Jean‐Luc; J. O’Connell, Philip

doi:10.1097/tp.0000000000003095

Public

Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group

Published in Transplantation • Dec 31, 2019

Authors:

Carrie A. Schinstock

Roslyn B. Mannon

Klemens Budde

Abstract

With the development of modern solid-phase assays to detect anti-HLA antibodies and a more precise histological classification, the diagnosis of antibody-mediated rejection (AMR) has become more common and is a major cause of kidney graft loss. Currently, there are no approved therapies and treatmen...

Subject

Medicine

Intensive care medicine

Transplantation

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!